Cargando…
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?
BACKGROUND: Vitamin D deficiency is one of the most common health issues in developed countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D(3) (25(OH)D(3)) levels that are too low due to the accumulation of vitamin D in adipose tissue. While the effects of a deficiency on th...
Autores principales: | Ozorowski, Mateusz, Wiciński, Michał, Wróbel, Łukasz, Fajkiel-Madajczyk, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052493/ https://www.ncbi.nlm.nih.gov/pubmed/35488267 http://dx.doi.org/10.1186/s12986-022-00666-4 |
Ejemplares similares
-
Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients
por: Wiciński, Michał, et al.
Publicado: (2021) -
Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020) -
Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D Genes
por: Muindi, Josephia R., et al.
Publicado: (2013) -
The effects of three regimens of cholecalciferol (vitamin D(3)) supplementation on vitamin D deficiency in non-obese and obese females
por: Imga, Narin Nasiroglu, et al.
Publicado: (2018) -
Response to Antenatal Cholecalciferol Supplementation Is Associated With Common Vitamin D–Related Genetic Variants
por: Moon, Rebecca J., et al.
Publicado: (2017)